196 related articles for article (PubMed ID: 21397094)
41. [Cervico-vaginal pathogens and contraception: microbiological observations].
Crotti D; Fonzo G
Quad Sclavo Diagn; 1987 Dec; 23(4):369-77. PubMed ID: 3508298
[TBL] [Abstract][Full Text] [Related]
42. Migration of levonorgestrel IUS in a patient with complex medical problems: what should be done?
Soleymani Majd H; El Hamamy E; Chandrasekar R; Ismail L
Arch Gynecol Obstet; 2009 Mar; 279(3):385-6. PubMed ID: 18568357
[TBL] [Abstract][Full Text] [Related]
43. Successful pregnancy following insertion of a levonorgestrel-releasing intrauterine system in two infertile patients with complex atypical endometrial hyperplasia.
Qi X; Zhao W; Duan Y; Li Y
Gynecol Obstet Invest; 2008; 65(4):266-8. PubMed ID: 18196936
[TBL] [Abstract][Full Text] [Related]
44. Levonorgestrel-releasing intrauterine system: uses and controversies.
Bahamondes L; Bahamondes MV; Monteiro I
Expert Rev Med Devices; 2008 Jul; 5(4):437-45. PubMed ID: 18573044
[TBL] [Abstract][Full Text] [Related]
45. Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding.
Wildemeersch D; Andrade A
Gynecol Endocrinol; 2010 May; 26(5):383-9. PubMed ID: 20192899
[TBL] [Abstract][Full Text] [Related]
46. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
[TBL] [Abstract][Full Text] [Related]
47. [Levonorgestrel releasing intrauterine spiral--contraception and therapeutic indications].
Kunz J
Praxis (Bern 1994); 2001 Mar; 90(11):442-52. PubMed ID: 11293937
[TBL] [Abstract][Full Text] [Related]
48. Nonbarrier contraceptives and vaginitis and vaginosis.
Roy S
Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1240-4. PubMed ID: 1951581
[TBL] [Abstract][Full Text] [Related]
49. Levonorgestrel-releasing intrauterine system: why do some women dislike it?
Daud S; Ewies AA
Gynecol Endocrinol; 2008 Dec; 24(12):686-90. PubMed ID: 19172537
[TBL] [Abstract][Full Text] [Related]
50. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial.
Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Yliskoski M; Vuorma S; Paavonen J
BJOG; 2007 May; 114(5):563-8. PubMed ID: 17439564
[TBL] [Abstract][Full Text] [Related]
51. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
52. Treatment of menorrhagia with an LNG-IUS.
Pakarinen P; Luukkainen T
Contraception; 2007 Jun; 75(6 Suppl):S118-22. PubMed ID: 17531601
[TBL] [Abstract][Full Text] [Related]
53. The impact of copper-containing and levonorgestrel-releasing intrauterine contraceptives on cervicovaginal cytology and microbiological flora: a prospective study.
Erol O; Simavlı S; Derbent AU; Ayrım A; Kafalı H
Eur J Contracept Reprod Health Care; 2014 Jun; 19(3):187-93. PubMed ID: 24738915
[TBL] [Abstract][Full Text] [Related]
54. Effects of contraception on cervical cytology: data from Mardin City.
Bariş II; Arman Karakaya Y
Turk Patoloji Derg; 2013; 29(2):117-21. PubMed ID: 23661348
[TBL] [Abstract][Full Text] [Related]
55. Frequency of Trichomonas vaginalis, Candida sp and Gardnerella vaginalis in cervical-vaginal smears in four different decades.
Adad SJ; de Lima RV; Sawan ZT; Silva ML; de Souza MA; Saldanha JC; Falco VA; da Cunha AH; Murta EF
Sao Paulo Med J; 2001 Nov; 119(6):200-5. PubMed ID: 11723534
[TBL] [Abstract][Full Text] [Related]
56. Clinical importance of detection of bacterial vaginosis, trichomonas vaginalis, candida albicans and actinomyces in Papanicolaou smears.
Güdücü N; Gönenç G; Işçi H; Yiğiter AB; Başsüllü N; Dünder I
Clin Exp Obstet Gynecol; 2012; 39(3):333-6. PubMed ID: 23157037
[TBL] [Abstract][Full Text] [Related]
57. Effects of intrauterine contraception on the vaginal microbiota.
Bassis CM; Allsworth JE; Wahl HN; Sack DE; Young VB; Bell JD
Contraception; 2017 Sep; 96(3):189-195. PubMed ID: 28624570
[TBL] [Abstract][Full Text] [Related]
58. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
[TBL] [Abstract][Full Text] [Related]
59. Chronic vulvovaginal candidiasis in patients using a levonorgestrel-containing intrauterine device.
Nguyen Y; Fischer G
Australas J Dermatol; 2018 Feb; 59(1):e39-e42. PubMed ID: 27957732
[TBL] [Abstract][Full Text] [Related]
60. Influence of contraceptive choice on vaginal bacterial and fungal microflora.
Donders G; Bellen G; Janssens D; Van Bulck B; Hinoul P; Verguts J
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):43-48. PubMed ID: 27638008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
